Melanoma screening
|
Melanoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Melanoma screening On the Web |
|
American Roentgen Ray Society Images of Melanoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.
Overview
The 1992-1994 free American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program provided broad skin cancer educational information to general public and enabled thousands of free expert skin cancer examinations. The 2001-2005 American Academy of Dermatology National Melanoma/Skin Cancer Screening Program emphasized on the use of HARMM criteria to identify the higher-risk subgroup of skin cancer screening population via assessment of multiple risk factors for MM hence, both reducing the cost & increasing the yields for suspected MM in future mass screening initiatives. Melanoma Genetics Program identifies the genetic causes of skin cancer, and provides genetic counseling to the individuals with strong family history of melanoma. Dermoscopy usage improves the ability of primary care physicians to triage lesions suggestive of skin cancer, thus saving from unnecessary expert consultations. Combination of dermoscopy and short-term sequential digital dermoscopy imaging (SDDI) in a primary care setting doubles the sensitivity for melanoma diagnosis and leads to >50% chance of reduction in excision or referral of benign pigmented lesions.
Screening
According to different studies going on for so many years, following data is available regarding the different methods/tools and their effectiveness for skin cancer screening:
- From 1992 to 1994, free American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program was launched which provided broad skin cancer educational information to general public and enabled almost 750,000 free expert skin cancer examinations which mostly found out thin, localized stage 1 melanomas with high projected 5-year survival rate[1][2]
- From 2001 to 2005, American Academy of Dermatology National Melanoma/Skin Cancer Screening Program was launched which led to the conclusion that HARMM criteria can be used to identify the higher-risk subgroup of skin cancer screening population via assessment of multiple risk factors for MM , which will not only reduce the cost but will also increase the yields for suspected MM in future mass screening initiatives[3]
- Melanoma Genetics Program identifies the genetic causes of skin cancer, and also provides genetic counseling to the individuals having a strong family history of melanoma[4][5][6][1][7][8][9]
- Dermoscopy usage improves the ability of primary care physicians to triage lesions which are suggestive of skin cancer and saves from unnecessary expert consultations[10]
- Combination of dermoscopy and short-term sequential digital dermoscopy imaging (SDDI) in a primary care setting doubles the sensitivity for melanoma diagnosis and also leads to >50% chance of reduction in excision or referral of benign pigmented lesions[11][12][13][14][15]
References
- ↑ 1.0 1.1 "Skin Cancer (Melanoma) Treatment Program - Massachusetts General Hospital, Boston, MA".
- ↑ Koh HK, Norton LA, Geller AC, Sun T, Rigel DS, Miller DR; et al. (1996). "Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program". J Am Acad Dermatol. 34 (6): 971–8. doi:10.1016/s0190-9622(96)90274-1. PMID 8647990.
- ↑ Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS (2007). "Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005". J Am Acad Dermatol. 57 (1): 60–6. doi:10.1016/j.jaad.2007.02.010. PMID 17490783.
- ↑ Gauwerky K, Ruzicka T, Berking C (2009). "[Skin cancer screening at the family doctor's office]". MMW Fortschr Med. 151 (25): 38–42, quiz 43. PMID 19739523.
- ↑ Treiber N, Huber MA, Scharffetter-Kochanek K, Schneider LA (2014). "[Early detection of skin cancer]". MMW Fortschr Med. 156 (4): 37–40. PMID 24908774.
- ↑ Mierzwa T, Zegarski W, Placek W, Zegarska B (2004). "[Skin cancer screening program in the population of Bydgoszcz]". Wiad Lek. 57 Suppl 1: 211–4. PMID 15884241.
- ↑ Bajaj S, Wolner ZJ, Dusza SW, Braun RP, Marghoob AA, DeFazio J (2019). "Total Body Skin Examination Practices: A Survey Study Amongst Dermatologists at High-Risk Skin Cancer Clinics". Dermatol Pract Concept. 9 (2): 132–138. doi:10.5826/dpc.0902a09. PMC 6502292 Check
|pmc=value (help). PMID 31106016. - ↑ Argenziano G, Zalaudek I, Hofmann-Wellenhof R, Bakos RM, Bergman W, Blum A; et al. (2012). "Total body skin examination for skin cancer screening in patients with focused symptoms". J Am Acad Dermatol. 66 (2): 212–9. doi:10.1016/j.jaad.2010.12.039. PMID 21757257.
- ↑ "Skin Cancer Screening: MedlinePlus Lab Test Information".
- ↑ Argenziano G, Puig S, Zalaudek I, Sera F, Corona R, Alsina M; et al. (2006). "Dermoscopy improves accuracy of primary care physicians to triage lesions suggestive of skin cancer". J Clin Oncol. 24 (12): 1877–82. doi:10.1200/JCO.2005.05.0864. PMID 16622262.
- ↑ Menzies SW, Emery J, Staples M, Davies S, McAvoy B, Fletcher J; et al. (2009). "Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial". Br J Dermatol. 161 (6): 1270–7. doi:10.1111/j.1365-2133.2009.09374.x. PMID 19747359.
- ↑ van der Rhee JI, Bergman W, Kukutsch NA (2010). "The impact of dermoscopy on the management of pigmented lesions in everyday clinical practice of general dermatologists: a prospective study". Br J Dermatol. 162 (3): 563–7. doi:10.1111/j.1365-2133.2009.09551.x. PMID 19832836.
- ↑ Dinnes J, Deeks JJ, Chuchu N, Ferrante di Ruffano L, Matin RN, Thomson DR; et al. (2018). "Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults". Cochrane Database Syst Rev. 12: CD011902. doi:10.1002/14651858.CD011902.pub2. PMC 6517096 Check
|pmc=value (help). PMID 30521682. - ↑ Ferrante di Ruffano L, Takwoingi Y, Dinnes J, Chuchu N, Bayliss SE, Davenport C; et al. (2018). "Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults". Cochrane Database Syst Rev. 12: CD013186. doi:10.1002/14651858.CD013186. PMC 6517147 Check
|pmc=value (help). PMID 30521691. - ↑ Ferrante di Ruffano L, Dinnes J, Deeks JJ, Chuchu N, Bayliss SE, Davenport C; et al. (2018). "Optical coherence tomography for diagnosing skin cancer in adults". Cochrane Database Syst Rev. 12: CD013189. doi:10.1002/14651858.CD013189. PMID 30521690.